Europe Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Product Type (Instruments, Assay Kits & Consumables), By Disease Type (Systemic Autoimmune Diseases), By Technology (Immunoassays, Indirect Immunofluorescence, Multiplex Assays, Molecular Diagnostics, Point-of-Care Testing, Other Technology), By End User (Hospitals & Clinics, Clinical Laboratories, Academic & Research Institutes, Other End Users) and By Country (U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2026-2034

Last Updated: July 08, 2026 | Author: Debashree B | Format:

Market Segmentation

  1. Europe Autoimmune Disease Diagnostics Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Assay Kits & Consumables
  2. Europe Autoimmune Disease Diagnostics Market, By Disease Type 2022-2034 (USD MILLION/ Units)
    1. Systemic Autoimmune Diseases
      1. Rheumatoid Arthritis
      2. S2 Systemic Lupus Erythematosus
      3. Scleroderma
      4. Vasculitis
      5. Inflammatory Bowel Disease
      6. Other Diseases
      7. Type 1 Diabetes
      8. Autoimmune Thyroid Diseases
  3. Europe Autoimmune Disease Diagnostics Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Immunoassays
    2. Indirect Immunofluorescence
    3. Multiplex Assays
    4. Molecular Diagnostics
    5. Point-of-Care Testing
    6. Other Technology
  4. Europe Autoimmune Disease Diagnostics Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals & Clinics
    2. Clinical Laboratories
    3. Academic & Research Institutes
    4. Other End Users
  5. Regional Europe Autoimmune Disease Diagnostics Market
    1. Europe
      1. Europe Europe Autoimmune Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Assay Kits & Consumables
      2. Europe Europe Autoimmune Disease Diagnostics Market By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
      3. Europe Europe Autoimmune Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassays
        2. Indirect Immunofluorescence
        3. Multiplex Assays
        4. Molecular Diagnostics
        5. Point-of-Care Testing
        6. Other Technology
      4. Europe Europe Autoimmune Disease Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Clinical Laboratories
        3. Academic & Research Institutes
        4. Other End Users
      5. U.K.
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      6. Germany
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      7. France
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      8. Spain
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      9. Italy
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      10. Russia
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      11. Nordic
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      12. Benelux
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users
      13. Rest of Europ
        1. Instruments
        2. Assay Kits & Consumables
        3. Systemic Autoimmune Diseases
          1. Rheumatoid Arthritis
          2. S2 Systemic Lupus Erythematosus
          3. Scleroderma
          4. Vasculitis
          5. Inflammatory Bowel Disease
          6. Other Diseases
          7. Type 1 Diabetes
          8. Autoimmune Thyroid Diseases
        4. Immunoassays
        5. Indirect Immunofluorescence
        6. Multiplex Assays
        7. Molecular Diagnostics
        8. Point-of-Care Testing
        9. Other Technology
        10. Hospitals & Clinics
        11. Clinical Laboratories
        12. Academic & Research Institutes
        13. Other End Users

We are featured on: